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Abstract Endogenous, constitutive soluble epoxide hydrolase in
mice 3T3 cells was localized via immunofluorescence microscopy
exclusively in peroxisomes, whereas transiently expressed mouse
soluble epoxide hydrolase (from clofibrate-treated liver) accu-
mulated only in the cytosol of 3T3 and HeLa cells. When the
C-terminal Ile of mouse soluble epoxide hydrolase was mutated
to generate a prototypic putative type 1 PTS (-SKI to -SKL), the
enzyme targeted to peroxisomes. The possibility that soluble
epoxide hydrolase-SKI was sorted slowly to peroxiosmes from
the cytosol was examined by stably expressing rat soluble
epoxide hydrolase-SKI appended to the green fluorescent
protein. Green fluorescent protein soluble epoxide hydrolase-
SKI was strictly cytosolic, indicating that -SKI was not a
temporally inefficient putative type 1 PTS. Import of soluble
epoxide hydrolase-SKI into peroxisomes in plant cells revealed
that the context of -SKI on soluble epoxide hydrolase was
targeting permissible. These results show that the C-terminal
-SKI is a non-functional putative type 1 PTS on soluble epoxide
hydrolase and suggest the existence of distinct cytosolic and
peroxisomal targeting variants of soluble epoxide hydrolase in
mouse and rat.
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1. Introduction
Epoxide hydrolyases (EH: EC3.3.2.3) consist of a small
family of at least ¢ve isoenzymes that catalyze the hydrolysis
of a variety of toxic epoxides into their corresponding diols
[1]. EH activities have been measured in at least two subcel-
lular compartments of mammalian cells, including the cytosol
(leukotrinene A4 EH and hepoxilin EH) and the endoplasmic
reticulum (xenobiotic microsomal EH and cholesterol-5,6-EH)
[1^4]. However, the precise compartmentalization of the ¢fth
EH, soluble EH (sEH), remains controversial. Although ini-
tial studies suggested that sEH was localized within the mito-
chondria [5,6], later experiments employing isopycnic centri-
fugation revealed that sEH was actually localized within
peroxisomes and the cytosol of mammalian cells [7,8]. Subse-
quent immunocytochemical analysis, however, suggested that
sEH was localized exclusively within the peroxisomes [9].
These authors speculated that the cytosolic compartmentali-
zation of sEH reported in earlier biochemical studies was
attributed to the fragmentation of the peroxisomes during
tissue homogenization and/or organelle isolation procedures.
More recently, however, Eriksson et al. [10] employed digito-
nin permeabilization studies of mice hepatocytes and demon-
strated that the majority of sEH was localized in the cytosol
with the remainder in peroxisomes. These results were sup-
ported by Arand et al. [11] who speculated that the dual local-
ization of sEH was attributable to a functionally-impaired or
functionally ine⁄cient peroxisomal targeting signal (PTS) lo-
cated at the C-terminus of the nascent enzyme.
Treatment of rodents with clo¢brate, a hypolipidemic drug,
causes the proliferation of peroxisomes and the induction of
peroxisomal enzymes involved in fatty acid L-oxidation [12].
Clo¢brate treatment, however, does not result in an increase
in peroxisomal sEH-speci¢c activity, whereas cytosolic sEH
activity increases as a result of protein synthesis [13]. The
di¡erential e¡ects of clo¢brate administration on cytosolic
and peroxisomal sEH has been considered in above studies
dealing with the subcellular localization of sEH in mammalian
cells, but a de¢nitive relationship has not been elucidated.
In this study, we investigated the subcellular compartmen-
talization of sEH in cultured mammalian and plant cells using
immuno£uorescence microscopy. In addition, we tested
whether the putative type 1 PTS (PTS1) on clo¢brate-induced
sEH, i.e. a C-terminal -Ser-Lys-Ile tripeptide (-SKI), was ca-
pable of targeting the enzyme (sEH-SKI) to cultured mamma-
lian and plant peroxisomes. Our results show that the dual
localization of sEH observed in mammalian cells is not a
consequence of the enzymes C-terminal of -SKI functioning
as an ine⁄cient PTS1. Instead, transiently and stably ex-
pressed, clo¢brate-induced sEH-SKI did not target to perox-
isomes, but remained in the cytosol.
2. Materials and methods
2.1. Mammalian and plant cell cultures
The contact-inhibited NIH Swiss mouse embryo cell line NIH3T3
and the HeLa cell line (American Type Culture Collection) were
maintained in Dulbecco’s modi¢ed Eagle’s medium (DMEM) contain-
ing 10% fetal calf serum (FCS) and 50 Wg/ml gentamycin sulfate. V79
Chinese hamster lung ¢broblast cells [14] were grown in DMEM with
10% FCS and 100 U/ml penicillin and 100 Wg/ml streptomycin. All
mammalian cells were maintained in a humidi¢ed incubator at 37‡C
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under 95% air and 5% CO2. Tobacco BY-2 (Nicotiana tabacum L. cv
Bright Yellow 2) cell suspension cultures were grown in darkness at
25‡C as described previously [15].
2.2. Plasmid construction
The murine sEH cDNA used in this study was isolated from a
cDNA library constructed from mRNA isolated from liver tissue of
mice that had been administered clo¢brate in their diet [16]. DNA
sequence within the NdeI and XhoI fragment of the mouse sEH
cDNA (includes the entire ORF) was modi¢ed by site-directed muta-
genesis as described [17] using the anti-sense primer 5P-TGGCTAA-
AGCTTGGAGGTCAC-3P. This mutation resulted in a substitution
of Leu for Ile at the C-terminus of mouse sEH (sEH-SKL). Mutant
(-SKL) and wild-type (-SKI) mouse sEH clones were then excised
from pKS+ (pBluescript, Stratagene) by digestion with NdeI and
XhoI, blunt-ended with Klenow and subcloned into SmaI-digested
pRTL2 [18] and SnaBI-digested pMT [19] for transient expression
in tobacco or mammalian cells, respectively (Table 1).
For the construction of GFP-rat sEH expression plasmids, the GFP
insert in the bacterial expression vector pBAD-GFP (A¡ymax) was
PCR-ampli¢ed using Pfu DNA polymerase (Stratagene) and oligonu-
cleotides 5P-TCGTGATCAGCCGCCATGGCTAGCAAAGGAGA-
AGA-3P and 5P-TCGTGATCAGATCTTTTGTATAGTTCATCCA-
TGCC-3P. The resulting fragment was digested with BclI and ligated
into the BamHI-site of the mammalian expression vector pcDNA1/
Amp (Invitrogen) to generate pcDNA1/Amp-GFP. Next, the XhoI/
DraI fragment from pRSET B-sEH1 encoding the entire ORF of
clo¢brate-induced rat sEH [20] was ligated into the SmaI/SalI site
of the cloning vector pSP64 Poly(A) (Promega). The resulting plas-
mid, pSP64-sEH, was digested with SstI and BstEII and religated in
the presence of double-stranded oligonucleotides generated by hybrid-
ization of the two fragments 5P-GTGACCTCCAAGCNGTAGTAG-
CT-3P and 5PACTACNGCTTGGAG-3P. Due to the degenerate code
of the oligonucleotide at the site of mutagenesis, four di¡erent con-
structs were obtained, resulting in an exchange of the last codon of
the rat sEH ORF. Finally, each of the di¡erent constructs were di-
gested with EcoRI and partially digested with BglII. The resulting
EcoRI/BglII fragments were inserted into the EcoRI/BglII sites of
pcDNA1/Amp-GFP to generate each of the GFP-rat sEH fusion
plasmids used in this study, i.e. GFP-rat sEH-SKI (wild-type),
-SKL, -SKP, -SKQ, and -SKR (Table 1).
All DNA manipulations were veri¢ed by manual (T7 Sequencing
Kit, Pharmacia) or TaqCycle automated sequencing (Applied Biosys-
tems) with dideoxy terminators.
2.3. Transient transfections and transformations
NIH3T3 and HeLa cells were grown on coverslips to approximately
50% con£uency, transfected with mouse sEH expression plasmids us-
ing LipofectACE reagent according to the manufacturer’s instructions
(Gibco BRL) and cultured in antibiotic-free DMEM without FCS for
24 h [19]. Cells were cultured for an additional 24 h in maintenance
medium and then processed for indirect, immuno£uorescence micro-
scopy.
Tobacco BY-2 cells were transiently transformed by microprojectile
bombardment with a helium biolistic particle delivery system accord-
ing to the manufacturer’s recommendations (Bio-Rad) [21]. Bom-
barded BY-2 cells were then left in unwrapped Petri dishes for 40 h
and then processed for indirect, immuno£uorescence microscopy.
2.4. Generation of V79 Chinese hamster stable cell lines
Stable transfection of V79 Chinese hamster cells was carried out by
the calcium phosphate precipitation technique [22]. Brie£y, approxi-
mately 7U105 cells were plated in 90 mm dishes and 24 h later, were
co-transfected with either wild-type or modi¢ed GFP-rat sEH con-
structs and the selection plasmid pPUR (Clontech) that confers pur-
omycin resistance. 24 h After transfection, cells were split 1:15 and
maintained with selection medium (maintenance medium supple-
mented with 5 Wg/ml puromycin). Resistant colonies appeared within
1^2 weeks and were subsequently isolated and maintained in selection
medium until immuno£uorescence microscopic analysis.
2.5. Immuno£uorescence microscopy
NIH3T3 and HeLa cells on coverslips were washed three times in
PBS, ¢xed in 3% (v/v) formaldehyde/PBS for 20 min and permeabi-
lized with 1% Triton X-100/PBS for 15 min [19]. For experiments
involving stable expression of GFP-rat sEH fusion proteins in V79
Chinese hamster cell lines, cells were grown on coverslips but not
formaldehyde-¢xed because £uorescence could be observed in living
cells. Tobacco BY-2 cells were prepared for immuno£uorescence mi-
croscopy as described previously [21]. For di¡erential permeabiliza-
tion experiments, NIH3T3, HeLa, and tobacco cells were permeabi-
lized with digitonin (25 Wg/ml) (Sigma) rather than Triton X-100 for
15 min to selectively permeabilize the plasma membrane [19,21].
Antibodies used for indirect immuno£uorescence were as follows:
rabbit anti-mouse sEH IgGs [23], rabbit anti-human erythrocyte cat-
alase (Calbiochem), rabbit anti-rat catalase IgGs (kindly provided by
Dariush Fahimi, University of Heidelberg), rabbit anti-cottonseed
catalase IgGs [24], goat anti-rabbit BODIPY IgGs (Molecular
Probes), goat anti-rabbit rhodamine IgGs and goat anti-rabbit Cy3
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Fig. 1. Immuno£uorescence localization of endogenous and wild-type or modi¢ed mouse sEH in cultured mammalian cells. Mice 3T3 (A^D) or
HeLa (E^H) cells were grown on coverslips and either non-transfected or transfected with DNA encoding wild-type or modi¢ed mouse sEH.
Cells were formaldehyde-¢xed and then visualized by immuno£uorescence microscopy. (A and B) Co-localization of endogenous sEH (A) and
endogenous catalase (B) in peroxisomes of non-transfected mice 3T3 cells. Arrows indicate obvious co-localizations. (C) Representative ¢eld of
non-transfected mice 3T3 cells with anti-mouse sEH IgGs omitted. (D) Cytosolic and peroxisomal localization of transiently expressed mouse
sEH and endogenous sEH, respectively, in mice 3T3 cells. (E) Cytosolic localization of transiently expressed mouse sEH in HeLa cells. (F and
G) Co-localization of transiently expressed mouse sEH-SKL (F) and endogenous catalase (G) in peroxisomes of HeLa cells. Arrows indicate
obvious co-localizations. (H) Representative ¢eld of non-transfected HeLa cells with anti-mouse sEH IgGs omitted. Bar in (A) = 10 Wm.
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IgGs (Jackson ImmunoResearch Laboratories). Immunostained cells
were mounted on glass slides in 90% (v/v) glycerol with n-propyl-
gallate (Sigma) to prevent bleaching of £uorescence and viewed using
either a Zeiss Axiovert 100 or a Mikrophot-FXA £uorescent micro-
scope. In experiments involving expression of GFP-rat sEH fusion
proteins, captured images were manipulated using Adobe Photoshop
software (Adobe Systems).
3. Results
3.1. Localization of mouse sEH in mammalian cells
As the ¢rst step towards studying the subcellular localiza-
tion of mammalian sEH, we examined endogenous sEH in
mice 3T3 cells. Fig. 1 shows the results of double, indirect
immuno£uorescence staining of non-transfected mice 3T3
cells permeabilized with Triton X-100 and incubated with
anti-mouse sEH IgGs (Fig. 1A) and anti-rat catalase IgGs
(Fig. 1B). In all cells examined, sEH staining exhibited a par-
ticulate immuno£uorescence pattern attributable to peroxiso-
mal localization, as evidence by co-localization of sEH with
endogenous peroxisomal catalase (Fig. 1A,B). No signi¢cant
immuno£uorescence staining attributable to the localization
of endogenous sEH in the cytosol was detected (Fig. 1A).
The £uorescence image attributable to peroxisomal sEH stain-
ing was not observed in cells when anti-mouse sEH IgGs were
omitted (Fig. 1C). These results suggest that endogenous sEH
is not cytosolic in murine cells but localized exclusively within
peroxisomes.
The subcellular localization of transiently expressed mouse
sEH in mouse 3T3 cells, however, was distinct from endoge-
nous peroxisomal sEH. When mouse 3T3 cells were trans-
fected with DNA encoding mouse sEH DNA and incubated
with anti-mouse sEH IgGs, both a punctate and di¡use cyto-
solic immuno£uorescence staining pattern was observed (Fig.
1D). These results were taken to indicate that endogenous and
introduced sEH localized to two distinct subcellular compart-
ments. That is, the punctate staining pattern was attributable
to the localization of endogenous sEH in peroxisomes as
shown in Fig. 1A and the di¡use staining pattern was the
result of introduced mouse sEH localized in the cytosol. Be-
cause the immunodetection of both introduced and endoge-
nous sEH in mouse cells hampered our ability to assess
whether a portion of transfected mouse sEH was actually
sorted from the cytosol to peroxisomes, we examined the lo-
calization of mouse sEH in HeLa cells. Preliminary experi-
ments revealed that antibodies to mouse sEH did not recog-
nize endogenous sEH in HeLa cells (data not shown). This is
supported by previous results showing that this antiserum
reacts much less strongly to the human sEH [23]. When
HeLa cells were transfected with mouse sEH DNA and incu-
bated with anti-mouse sEH IgGs, the immuno£uorescence
staining was di¡use (cytosolic) with no indication of peroxi-
somal labelling (Fig. 1E). This observation con¢rms the re-
sults illustrated in Fig. 1D, i.e. transiently expressed mouse
sEH remains localized within the cytosol of mammalian cells.
However, when the C-terminal Ile of mouse sEH was replaced
with Leu thereby generating the prototypic PTS1 (i.e. -SKL),
the transiently expressed enzyme (sEH-SKL) was convincingly
directed to HeLa peroxisomes. Fig. 1F,G illustrate the co-
localization of sEH-SKL with peroxisomal catalase. Authen-
ticity of the targeting of mouse sEH-SKL to HeLa peroxi-
somes was reinforced in control experiments where anti-
mouse sEH IgGs were omitted (Fig. 1H). In addition, di¡er-
ential detergent permeabilization experiments either with dig-
itonin (permeabilizes only the plasma membrane) or Triton
X-100 (permeabilizes all cellular membranes) showed that
mouse sEH-SKL was actually imported into the peroxisome
matrix rather than attached to the boundary membrane on
the cytosolic side of the organelle (data not shown).
3.2. Stably expressed rat sEH is localized in the cytosol of
mammalian cells
The cytosolic localization of transiently expressed wild-type
mouse sEH-SKI showed above could be interpreted to show a
temporally ine⁄cient uptake of sEH-SKI into peroxisomes.
That is, it is possible that a small proportion of introduced
mouse sEH-SKI was imported into peroxisomes after 24 h
and more would be imported with longer periods of time.
Support for this premise comes from previous biochemical
studies whereby the majority of mammalian sEH was reported
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Table 1
Summary of subcellular localizations of various mouse sEH and GFP-rat sEH proteins in di¡erent cell types
Plasmids Subcellular localization
NIH3T3 HeLa V79 BY-2
pMT mouse sEH-SKI C* C







pRTL2 mouse sEH-SKI P
pRTL2 mouse sEH-SKL P
(C) Cytosol, (P) Peroxisomes.
*Denotes that endogenous, peroxisomal sEH was detected with anti-mouse sEH IgGs.
Fig. 2. Subcellular localization of stably-expressed GFP-rat sEH fu-
sion proteins in V79 Chinese hamster cells. (A) Cytosolic localiza-
tion of GFP-rat sEH-SKI. (B) Peroxisomal localization of rat sEH-
GFP-SKL. Bar in (A) = 10 Wm.
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to reside in the cytosol with the remaining portion in perox-
isomes [10,25]. To test this possibility, several V79 Chinese
hamster cell lines stably expressing di¡erent GFP-rat sEH
proteins were generated. As shown in Fig. 2A, stably ex-
pressed GFP-wild-type rat sEH-SKI was uniformly dispersed
throughout the cytosol, not in a particulate pattern reminis-
cent of peroxisomal localization. Similar cytosolic localiza-
tions of GFP £uorescence were observed for GFP alone and
for several other GFP constructs : GFP-rat sEH-SKP, -SKQ
and -SKR (Table 1, photographs not shown). In constructs
where Ile was replaced with Leu, however, the resulting fusion
protein (GFP-rat sEH-SKL) was obviously sorted to peroxi-
somes (punctate £uorescence) without cytosolic staining (Fig.
2B). These observations support our interpretations from our
results of transient transfection studies. That is, the C-termi-
nal -SKI of sEH does not serve as a functional targeting
signal for sorting sEH to mammalian peroxisomes even over
an extended period of time.
3.3. Mouse sEH is sorted to peroxisomes in plant cells
We demonstrated previously in plant cells that a wide range
of amino acid resides were functional within the PTS1 and
that this range was considerably greater than those reported
for the targeting of proteins to mammalian peroxisomes [21].
This knowledge prompted us to determine whether the C-ter-
minal -SKI of mammalian sEH could indeed serve as a func-
tional PTS1 in plant cells. DNA encoding mouse sEH-SKI
was transiently expressed in tobacco BY-2 suspension culture
cells. Fig. 3A,B show that mouse sEH-SKI was sorted to
peroxisomes as evidenced by its co-localization with peroxiso-
mal catalase. Results of the di¡erential detergent permeabili-
zation experiments revealed that transiently expressed mouse
sEH actually was imported into the peroxisomes (data not
shown). Fig. 3C shows that when Ile at the C-terminus of
mouse sEH was replaced with Leu (sEH-SKL), peroxisomal
targeting was preserved.
4. Discussion
The PTS1, a C-terminal uncleaved tripeptide -SKL motif,
i.e. small basic hydrophobic residues, has been shown to be
capable of directing proteins to the matrix of peroxisomes in
evolutionary diverse organisms including mammals, yeast, try-
panosomes and plants [26,27]. However, it has been experi-
mentally shown that certain amino acid residues do not func-
tion within the tripeptide in various organisms despite the fact
that they have characteristics similar to those de¢ned by the
prototypic SKL motif. For example, substitution of Ile for
Leu (both hydrophobic) at the 31 position of the PTS1 abol-
ished targeting of proteins to mammalian peroxisomes [28],
whereas Ile at the 31 position was functional for targeting
proteins to yeast, trypanosome and plant peroxisomes
[21,29,30]. Our working hypothesis, therefore, was that intro-
duced wild-type mouse and rat sEH, both possessing a
C-terminal -SKI [16,20], would accumulate in the cytosol
and not target to peroxisomes in cultured mammalian cells.
This hypothesis was not in accordance with interpretations
made from previous studies where sEH was believed to be
localized only in the peroxisomes [9], or in both peroxisomes
and the cytosol [7,8,10,25]. Our results indicate that -SKI does
not function as a PTS1, leading us to conclude that sEH-SKI
is a cytosolic enzyme. This conclusion, however, must be rec-
onciled with our immuno£uorescence detection with anti-sEH
IgGs of endogenous sEH exclusively within peroxisomes in
mice 3T3 cells (Fig. 1A) and with numerous biochemical stud-
ies demonstrating the cytosolic and peroxisomal localization
of sEH in renal and hepatic tissues [13].
A possible explanation for the observed dual localization of
sEH in mammalian cells is that the transient expression sys-
tem employed herein (lipofection) did not provide adequate
time for introduced sEH-SKI to be redirected from the cyto-
sol to peroxisomes. That is, the observed localization of sEH-
SKI in the cytosol simply could be interpreted as a kinetic
manifestation whereby the introduced enzyme was targeted
slowly to peroxisomes. This premise comes from Arand et
al. [11] who proposed that the C-terminal -SKI of mammalian
sEH functions as an impaired (temporally ine⁄cient) PTS1
due to the Ile at the 31 position. From our results with stably
expressed GFP constructs, this does not seem to be a likely
explanation. GFP-sEH-SKI (and other modi¢ed constructs)
remained in the cytosol (Fig. 2A, Table 1), with no evidence
of punctate staining, thus, time was not a limiting factor for
-SKI-directed targeting in mammalian cells. The context of
-SKI at the C-terminus of sEH also does not appear to be
the reason for the lack of peroxisomal targeting. Transiently-
introduced mouse sEH-SKI was imported into plant peroxi-
somes (Fig. 3A,B) and a substitution of Leu for Ile at the 31
position (-SKL-COOH) on mouse and rat sEH resulted in
their import into peroxisomes in both plant (Fig. 3D) and
mammalian cells (Figs. 1F and 2B). Taken together, these
observations indicated that the inability of introduced sEH-
SKI to target to mammalian peroxisomes was not the result
of its C-terminal -SKI being a temporally ine⁄cient PTS1, or
being spatially inaccessible to targeting signal receptors. In-
stead, introduced sEH-SKI seems to be an isoform variant of
endogenous peroxisomal sEH.
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Fig. 3. Subcellular localization of transiently expressed wild-type or modi¢ed mouse sEH in tobacco BY-2 cells. Tobacco cells were biolistically
bombarded with DNA encoding wild-type or modi¢ed mouse sEH, formaldehyde-¢xed and then visualized by immuno£uorescence microscopy.
(A and B) Colocalization of mouse sEH-SKI (A) and catalase (B) in peroxisomes of a transiently transformed cell. Arrows indicate obvious
co-localizations. (C) Peroxisomal localization of mouse sEH-SKL in a transiently transformed cell. Bar in (A) = 10 Wm.
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The evidence suggests that two immuno-related forms (cy-
tosolic and peroxisomal) of sEH exist in mammalian cells.
Both forms of sEH may be encoded by one gene and the
resulting gene products modi¢ed by one or possibly more
pre- and/or post-translational mechanisms, e.g. multiple tran-
scription initiation, alternative splicing of a common tran-
script, or post-translational modi¢cations. There are several
documented examples in which a single gene encodes proteins
that are post-translationally targeted to an organelle, or re-
main in the cytosol [31]. For example, Bulitta et al. [32] re-
ported that a single gene encoded the cytosolic and peroxiso-
mal forms of guinea pig catalase.
Another reasonable consideration is that the two immu-
norelated forms of sEH are the products of two genes. Ad-
ministration of the hypolipidemic drug clo¢brate in the diets
of rodents causes an increase in cytosolic sEH activity in liver
cells, whereas peroxisomal sEH activity appears to be unal-
tered [33^36]. Hollinshead and Meijer [9], on the other hand,
showed that clo¢brate treatment did not lead to an increase in
the cytosolic form of sEH. Both the mouse and rat sEH
cDNAs employed in this study were isolated from cDNA
libraries constructed from mRNA isolated from liver tissue
of animals that had been administered clo¢brate in their
diet [16,20]. It is possible, therefore, that the sEH-SKI cDNAs
represent the clo¢brate induced cytosolic form and not the
endogenous, constitutive peroxisomal sEH that was detected
in Fig. 1A. Both the constitutive and the induced forms of
mouse sEH have previously been shown to be immunologi-
cally indistinguishable using our antibody [23]. Evidence sup-
porting a model for a constitutive sEH being targeted to and
imported into peroxisiomes comes from studies of an sEH
cDNA isolated from a human liver library made from cells
that were not treated with clo¢brate [37]. The deduced amino
acid sequence revealed that this enzyme possesses a C-termi-
nal -SKM tripeptide. Although it is not yet known whether
this constitutive form of human sEH is localized exclusively
within peroxisomes, a C-terminal -SKM has been shown in
numerous studies to direct import of proteins into mammalian
cell peroxisomes in vivo [19,28,38] and in vitro [39].
This paper presents compelling evidence that the dual local-
ization of sEH in rodents is not the consequence of a single
form of the enzyme localized in both the cytosol and perox-
isomes as a consequence of an ine⁄cient PTS1 (-SKI-COOH).
Instead, we suggest that two distinct, yet immunorelated,
forms of sEH are localized in these two separate subcellular
compartments.
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